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Introduction:
Approximately one third of the Army's completed suicides last year occurred in the post-deployment period (Alvarez 2009 ), highlighting the importance of studying high-risk suicidal veteran populations. This project proposes two related studies. The first project is a randomized clinical trial of 120 veterans identified with highrisk suicidal behavior comparing the efficacy of Dialectical Behavioral Therapy (DBT) vs. treatment as usual (TAU) on suicidal behavior as a primary outcome measure. A second aim of the project is to examine group differences between 150 veterans at high risk for suicide and 150 veterans at low risk in a variety of symptom domains. The goal of this will be to identify symptoms associated with suicidal behavior that may advise future treatment.
We will assess symptom domains including mood and substance use in our veteran population by comparing symptoms in low vs. high risk veterans recently discharged from the James J Peters VAMC (JJPVAMC) psychiatric inpatient unit. In addition, we will explore indices of interpersonal function and measure features that have some evidence of offering protection from suicide, which could be viewed as resilience factors. A particular emphasis of the present project is to characterize the nature of the interpersonal dysfunction in high risk individuals, as there exists very good evidence that social isolation, or a lack of a sense of "belonging" puts people at particularly high risk for suicide, in particular in a military sample . We intend to assess the impact of DBT vs. TAU on these symptom domains in addition to their impact on suicidal behavior.
Body:
In October 2011, a supplement to this project was approved to add a physiological measure, affective startle, to the baseline assessment and post-DBT treatment.
Aim 1 relates to a randomized clinical trial of Dialectical Behavior Therapy (DBT) vs. treatment as usual (TAU) in 120 veterans recently hospitalized with high-risk suicidal behavior. This will be accomplished under the leadership of Dr. Marianne Goodman, James J. Peters VAMC, Bronx, NY 10468 Aim 1: To examine, in a randomized controlled trial (RCT), the efficacy of a 6 month treatment with standard DBT (weekly individual sessions, skills training group and telephone coaching as needed) as compared to TAU in 120 veterans recently discharged from an acute psychiatric inpatient stay with high risk suicidal behavior. The primary treatment outcome will be a quantification of suicidal events, as assessed by the Columbia Suicide Severity Rating Scale, which measures suicide attempts, plans and preparations. Our study will be powered to examine treatment assignment differences in this measure. Secondary outcomes will include suicidal ideation, parasuicidal events, treatment compliance, depressed mood, substance abuse and hopelessness.
This aim involves recruiting 120 veterans off the JJPVA "high-risk" suicide list; a designation made primarily after psychiatric inpatient admission for serious suicidal behavioral. High-risk (HR) suicide subjects will undergo a comprehensive diagnostic interview prior to entering the treatment study. Subjects will receive 6 months of TAU vs. DBT but both groups will continue to receive standard psychopharmacology and case management services from their clinic providers. Subjects will receive a battery of assessments at month 6, 12 and 18.
Aim 2 relates to a comparison of high-risk and low-risk suicidal veterans in interpersonal functioning and resilience, in an effort to identify intermediate symptoms that are closely associated with HR suicidal behavior. This will be accomplished under the leadership of Dr. Marianne Goodman, James J. Peters VAMC, Bronx NY 10468 Aim 2: To recruit veterans recently discharged from an acute psychiatric inpatient stay comparing 150 veterans with HR suicidal behavior to 150 veterans without such behavior (LR) in symptom domains focusing on interpersonal functioning and resiliency.
Aim 3 is exploratory and examines the effect of treatment (DBT or TAU) on the putative intermediate symptom domains associated with HR suicidal behavior of interpersonal functioning and resiliency. This will be accomplished under the leadership of Dr. Marianne Goodman James J. Peters VAMC, Bronx NY 10468 Aim 3: To explore the effect of DBT on the candidate intermediate symptoms of interpersonal functioning and resiliency associated with HR suicidal behavior.
Promised work:
Parent ProjectThe first 3 months is devoted to training the raters on our assessment and diagnostic battery while we await regulatory approvals. During months 3-6, we expect to perform thirty baseline assessments and 15 high-risk subjects will be randomized to treatment. During months 6-12, 12-18, 18-24, 24-30 , we expect that thirty highrisk and thirty low-risk suicidal subjects will receive baseline assessments during each 6 month block. We anticipate that 25 of the high-risk subjects will proceed into treatment during each one of the time blocks. Months 30-36 will target 30 total additional assessments for baseline high and low-risk subjects with 5 of the HR individuals being randomized for treatment. The baseline assessment is a more comprehensive evaluation and we estimate that it will take approximately 6-7 hours with follow-up assessments requiring 1-2 hours.
While we met recruitment goals for Aim 1 of the study, our recruitment for the RTC fell behind. In order to continue recruitment we requested and were granted a fifth year, no cost extension. The Table below reflects promised work, and new numbers with the 5th year added.
Baseline assessments (50% HR, 50% LR)

Randomized to treatment (HR only)
Follow-up assessments 6mo 12 mo 18mo 
New year 4 target-60
Actual 65 293 to date (goal 300)
New year 4 target-25
Actual 15 
IRB approval
Towards accomplishing these aims, we received approval from our local IRB 7/9/09 and local Research and Development approval on 7/15/2009; prior to official funding of the project. This allowed us to pilot the intervention, assessments and randomization procedure. Dept of Defense approval was obtained on 4/27/2010; almost four months later that we had projected in our initial statement of work.
Recruitment
No-cost extension year: During our no-cost extension year, we focused solely on increasing our female Veteran subject pool in order to be able to do gender analyses. In addition, we realized that our LR pool of female veterans needed to be augmented. During this time period, we recruited and successfully assessed an additional 11 females who completed our baseline assessment and affective startle paradigm
For the treatment trial, during our no cost extension year, we completed follow-ups.
Over the entire course of the study, 384 veterans have signed consent (248 high-risk subjects and 136 low-risk subjects) and 340 (221 high-risk and 119 low-risk) have completed baseline assessments. With these numbers, we have surpassed our goal of 300 completed assessments. However, recruitment for the treatment trial remained limited and we randomized a total of 93 subjects to the trial and 53 completed the 6-month treatment.
Summary of Entire Parent Study to date
Over the course of the project-93 subjects have been randomized (to 45 TAU/48 to DBT). 53 subjects have completed the 6-month treatment trial; 25 for DBT and 28 for TAU.
Longitudinal Follow-up at 12 and 18 months: 49 subjects have completed 12-month follow up to date including-22 DBT subjects and 27 TAU subjects and 43 subjects have completed the entire study (e.g. 18-month completers) including 19 DBT and 24 TAU subject.
Total: 340 of 300 completed baseline assessments (exceeded goals) 93 of 120 randomized to clinical trial Progress Pertaining to Aim #1 Our Statement of work projected that by study completion we will have 300 baseline assessments finished. We completed 340, and during our no-cost extension year targeted females in order to perform gender sub-analyses. Data analysis was the focus of our no-cost extension year and we generated several manuscripts. Interim analyses have yielded findings pertaining to the importance of Axis I diagnoses of substance abuse, Axis II diagnoses of borderline personality disorder and responses on the interpersonal psychological survey as important risk factors for identifying "high-risk" veterans (see Figure 1) .
The identification of the interpersonal psychological survey as a critical instrument has led us to further examine its contents through a computerized implicit task assessment that we will be piloting in year 5 (see Figure 2) . Progress Pertaining to Aim #3 There were no significant differences found between treatment groups in the domains of interpersonal functioning nor resiliency.
Problems Accomplishing Tasks
With Hurricane Sandy, the Manhattan VA hospital was closed for upwards of 5 months. This lead to disruptions of care at our facility, as Manhattan patients sought treatment temporarily at our hospital. This complicated RCT recruitment efforts as pts were less likely to enroll in a longitudinal study that would require changing the location of their outpatient care beyond the expected time of Manhattan VA's closure.
SUPPLEMENT:
In addition to our three aims for the parent study, we added three additional aims for the supplemental study:
Supplement Aim 1 is to conduct a nonverbal and objective psychophysiological assessment of emotion processing using the affective startle paradigm to test whether it might serve as a potential biomarker for differentiating levels of suicidality. This will be accomplished under the leadership of Drs. Marianne Goodman and Erin Hazlett, James J. Peters VAMC, Bronx NY 10468 Aim 1. To examine the magnitude, time course, and rate of habituation of the startle eyeblink response during unpleasant, neutral, and pleasant pictures in 150 veterans with varying levels of suicidality; 60 veterans with a recent suicide attempt (during past 3 months), 60 veterans with suicidal ideation but no history of attempts, and 30 healthy veteran controls (i.e. no current psychiatric diagnosis).
This aim will be accomplished by adding the affective startle modulation paradigm to our current assessment battery of high-and low-risk suicidal subjects. Eligible subjects enrolled in the DoD funded parent project will participate in a 1-hour psychophysiology session at the MIRECC psychophysiology laboratory where we will record our primary variable of interest, namely the affective startle eyeblink response at baseline and 6 months for those enrolled in the DoD treatment trial. During this session, participants will view an intermixed series of unpleasant, neutral, and pleasant pictures from a standardized picture set. For each of the 3 picture conditions, we will examine three measures related to affective startle eyeblink modulation which is our psychophysiological measure of emotion processing: (1) the amplitude of the startle eyeblink response; (2) the time course of emotion processing by presenting the startle probes at different times during and post-picture processing; and (3) the rate of habituation of the startle eyeblink response. Aim 2 investigates the relationship of Axis II diagnosis, suicidality and affective startle. The collected data for Aim 2 will be used to explore this question.
Supplement
Supplement Aim 3 (No-Cost Extension)
is to explore gender differences between male and female veterans regarding affective startle modulation and using lifetime number of suicide attempts as a continuous variable of interest. Fifty female veterans will be compared with fifty male veterans for this analysis. This will be accomplished under the leadership of Drs. Marianne Goodman and Erin Hazlett, James J. Peters VAMC, Bronx NY 10468
Aim 3 investigates the relationship of gender, suicidality and affective startle. We will investigate potential differences in affective startle response across gender and suicide status. The project was awarded funding on 9/24/2011. In its first 12 months, the research team was incredibly effective in mobilizing resources and enrolling and testing 94 subjects at baseline and completing 1 6-month follow-up. Over the next 12-month period (10/1/12  9/30/13), the team was similarly effective with recruitment, testing an additional 55 subjects at baseline and 13 at 6-months following the treatment trial. In the 12-month period (10/1/13  9/30/14), we have tested additional 21 subjects at baseline and 9 at 6-months. The vast majority of these new participants were female (18/19), as we redoubled efforts to recruit from this population at the JJPVAMC. During the no-cost extension year, we added 6 additional females. These figures bring the cumulative total of baseline and 6-month numbers to 177 subjects and 23 subjects respectively.
Supplement Promised Work:
Progress Pertaining to Supplement Aim #1
Since receiving funding, we have run 177 patients at baseline, exceeding our goals, and have done 23 6-month follow-ups and therefore have met our recruitment goals for supplement Aim #1. The overall breakdowns are as follows: **In addition, using data from the treatment trial participants who received affect startle, amplitude to unpleasant pictures was used prospectively to examine prospective suicide attempt risk. Increased amplitude to unpleasant pictures was significantly associated with prospective suicide attempt in a small sample of treatment participants.
Progress Pertaining to Supplement Aim # 2
See information pertaining to Aim #1, specifically figure #4 above.
Progress Pertaining to Supplement Aim # 3 (NCE)
A newly added Aim for our approved No-Cost Extension was to continue to gather data from female participants. Female sub-analyses are still being conducted.
Problems Accomplishing Tasks
We did not experience any difficulty recruiting for this project and are in fact were ahead of schedule.
Key Research Accomplishments for both Parent and Supplement Projects
We have just completed year 5 of the parent study and no-cost extension for the affective startle supplement.
 Since DoD IRB approval (4/27/10): parent subject recruitment has been brisk. 384 Veteran subjects have signed consent.
 340 (out of promised 300) subjects completed baseline assessments. Our preliminary baseline data highlights the importance of Axis II psychopathology, in particular, borderline personality disorder as a risk factor for high-risk suicidal behavior. This is relevant as the disorder is often under recognized in VA settings and not even listed in the Uniform Services Package, the document listing required services for Veterans.
Enhanced Treatment as Usual and DBT are both effective treatments for suicidal veterans, however there is no significant difference between treatments and DBT results in enhanced treatment delivery needs. Future directions for research should be targeted to better engagement of high risk suicidal veterans, who do not follow up with outpatient psychotherapy treatments as both groups had high drops out in this subset. These individuals were primarily male, homeless and abusing substances.
Regarding our supplemental funding for affective startle, a psychophysiological assessment tool, there does appear to be a significant relationship between the affective startle response to negative picture probes and number of suicide attempts. These results suggest that the processing of negative emotion is a critical element of suicide attempt history. Future studies using affective startle include whether this measure can predict those at suicide risk prospectively. We are currently piloting a portable version of the affective startle assessment which will allow us to assess individuals in different setting (e.g. emergency room, inpatient unit, off campus locations). We continue to analyze our data for gender differences.
